{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:51:50Z","timestamp":1775263910661,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.hrtlng.2018.09.010","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T09:07:18Z","timestamp":1541408838000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mucoactive agents for adults with acute lung conditions: A systematic review"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5572-1644","authenticated-orcid":false,"given":"Benjamin J.","family":"Tarrant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin Le","family":"Maitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9884-5463","authenticated-orcid":false,"given":"Lorena","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjana","family":"Steward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda M.","family":"Button","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-0652","authenticated-orcid":false,"given":"Bruce R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2061-845X","authenticated-orcid":false,"given":"Anne E.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.hrtlng.2018.09.010_bib0001","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4187\/respcare.04087","article-title":"Aerosol medications for treatment of mucus clearance disorders","volume":"60","author":"Rubin","year":"2015","journal-title":"Respir Care"},{"issue":"7","key":"10.1016\/j.hrtlng.2018.09.010_bib0002","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4187\/respcare.07520859","article-title":"Mucolytics, expectorants, and mucokinetic medications","volume":"52","author":"Rubin","year":"2007","journal-title":"Respir Care"},{"issue":"Suppl 1","key":"10.1016\/j.hrtlng.2018.09.010_bib0003","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1016\/j.prrv.2006.04.198","article-title":"The pharmacologic approach to airway clearance: mucoactive agents","volume":"7","author":"Rubin","year":"2006","journal-title":"Paediatr Respir Rev"},{"issue":"4","key":"10.1016\/j.hrtlng.2018.09.010_bib0004","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1517\/14740330903036083","article-title":"Inhaled therapeutics for prevention and treatment of pneumonia","volume":"8","author":"Safdar","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.hrtlng.2018.09.010_bib0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1378\/chest.129.1.124","article-title":"Assessing the effects of racemic and single-enantiomer albuterol on airway secretions in long-term intubated patients","volume":"129","author":"O'Riordan","year":"2006","journal-title":"Chest"},{"issue":"1-4","key":"10.1016\/j.hrtlng.2018.09.010_bib0006","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000149813","article-title":"DNA quantification and fragmentation in sputum after inhalation of recombinant human deoxyribonuclease","volume":"22","author":"Riethmueller","year":"2008","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"10.1016\/j.hrtlng.2018.09.010_bib0007","first-page":"138","article-title":"Postoperative pulmonary complications","volume":"76","author":"Canet","year":"2010","journal-title":"Minerva Anestesiol"},{"issue":"116","key":"10.1016\/j.hrtlng.2018.09.010_bib0008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1183\/09059180.00003510","article-title":"Mucoactive drugs","volume":"19","author":"Balsamo","year":"2010","journal-title":"Eur Respir Rev"},{"issue":"7","key":"10.1016\/j.hrtlng.2018.09.010_bib0009","article-title":"Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis","author":"Tam","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.hrtlng.2018.09.010_bib0010","article-title":"Timing of hypertonic saline inhalation for cystic fibrosis","author":"Elkins","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.hrtlng.2018.09.010_bib0011","article-title":"Inhaled mannitol for cystic fibrosis","author":"Nolan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.hrtlng.2018.09.010_bib0012","article-title":"Dornase alfa for cystic fibrosis","author":"Yang","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.hrtlng.2018.09.010_bib0013","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/resp.13047","article-title":"Mucoactive agents for chronic, non-cystic fibrosis lung disease: a systematic review and meta-analysis","volume":"22","author":"Tarrant","year":"2017","journal-title":"Respirology"},{"issue":"10","key":"10.1016\/j.hrtlng.2018.09.010_bib0014","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/17476348.2017.1359090","article-title":"The role of mucoactive agents in the mechanically ventilated patient: a review of the literature","volume":"11","author":"Icard","year":"2017","journal-title":"Expert Rev Respir Med"},{"issue":"7","key":"10.1016\/j.hrtlng.2018.09.010_bib0015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.4187\/respcare.04086","article-title":"Pharmacologic agents that promote airway clearance in hospitalized subjects: a systematic review","volume":"60","author":"Sathe","year":"2015","journal-title":"Respir Care"},{"issue":"7","key":"10.1016\/j.hrtlng.2018.09.010_bib0016","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S2213-2600(16)30098-4","article-title":"Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study","volume":"4","author":"Iwashyna","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hrtlng.2018.09.010_bib0017","series-title":"Admitted Patient Care 2016\u201317: Australian Hospital Statistics","year":"2018"},{"key":"10.1016\/j.hrtlng.2018.09.010_bib0018","series-title":"Emergency Department Care 2016\u201317: Australian Hospital Statistics","year":"2017"},{"issue":"9","key":"10.1016\/j.hrtlng.2018.09.010_bib0019","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4187\/respcare.07521176","article-title":"Mucoactive agents for airway mucus hypersecretory diseases... includes discussion","volume":"52","author":"Rogers","year":"2007","journal-title":"Respir Care"},{"issue":"4","key":"10.1016\/j.hrtlng.2018.09.010_bib0020","article-title":"Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome","author":"Adhikari","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hrtlng.2018.09.010_bib0021","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","year":"2011"},{"issue":"6","key":"10.1016\/j.hrtlng.2018.09.010_bib0022","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/jamp.2011.0954","article-title":"Dornase alpha compared to hypertonic saline for lung atelectasis in critically ill patients","volume":"25","author":"Youness","year":"2012","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"2","key":"10.1016\/j.hrtlng.2018.09.010_bib0023","doi-asserted-by":"crossref","first-page":"218.e1","DOI":"10.1016\/j.jcrc.2012.09.015","article-title":"Inhaled Dornase alfa (Pulmozyme) as a noninvasive treatment of atelectasis in mechanically ventilated patients","volume":"28","author":"Zitter","year":"2013","journal-title":"J Crit Care"},{"issue":"4","key":"10.1016\/j.hrtlng.2018.09.010_bib0024","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/thx.51.4.429","article-title":"Evaluation of nebulised acetylcysteine and normal saline in the treatment of sputum retention following thoracotomy","volume":"51","author":"Gallon","year":"1996","journal-title":"Thorax"},{"issue":"15","key":"10.1016\/j.hrtlng.2018.09.010_bib0025","first-page":"2875","article-title":"Mucosolvan serves to optimize perioperative airway management for NSCLC patients in fast track surgery: a randomized placebo controlled study","volume":"19","author":"Wang","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.hrtlng.2018.09.010_bib0026","first-page":"309","article-title":"Evaluation of the effect of nebulized n-acetylcysteine on respiratory secretions in mechanically ventilated patients: randomized clinical trial","volume":"40","author":"Masoompour","year":"2015","journal-title":"Iran J Med Sci"},{"key":"10.1016\/j.hrtlng.2018.09.010_bib0027","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jcrc.2016.06.022","article-title":"Is inhaled prophylactic heparin useful for prevention and management of pneumonia in ventilated ICU patients?","volume":"35","author":"Bandeshe","year":"2016","journal-title":"J Crit Care"},{"key":"10.1016\/j.hrtlng.2018.09.010_bib0028","first-page":"A6809","article-title":"Safety of administering dry powder mannitol to stimulate sputum clearance in intubated intensive care patients with sputum retention: a pilot study","volume":"185","author":"Chan","year":"2012","journal-title":"Am J Resp Crit Care Med"},{"issue":"5","key":"10.1016\/j.hrtlng.2018.09.010_bib0029","doi-asserted-by":"crossref","first-page":"R180","DOI":"10.1186\/cc9286","article-title":"Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial","volume":"14","author":"Dixon","year":"2010","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.hrtlng.2018.09.010_bib0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0310057X1604400106","article-title":"A trial of nebulised heparin to limit lung injury following cardiac surgery","volume":"44","author":"Dixon","year":"2016","journal-title":"Anaesth Intensive Care"},{"issue":"4","key":"10.1016\/j.hrtlng.2018.09.010_bib0031","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4103\/ejb.ejb_24_17","article-title":"Does nebulized heparin have value in acute respiratory distress syndrome patients in the setting of polytrauma?","volume":"11","author":"Saleh","year":"2017","journal-title":"Egypt J Bronchol"},{"issue":"3","key":"10.1016\/j.hrtlng.2018.09.010_bib0032","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.arbres.2012.09.011","article-title":"Experience with lung resection in a fast-track surgery program","volume":"49","author":"Padilla Alarcon","year":"2013","journal-title":"Arch Bronconeumol"},{"issue":"1","key":"10.1016\/j.hrtlng.2018.09.010_bib0033","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13613-016-0138-4","article-title":"Nebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysis","volume":"6","author":"Glas","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"2","key":"10.1016\/j.hrtlng.2018.09.010_bib0034","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jval.2012.12.003","article-title":"Understanding the costs of care for cystic fibrosis: an analysis by age and health state","volume":"16","author":"van Gool","year":"2013","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.hrtlng.2018.09.010_bib0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1179\/108331906X163441","article-title":"Clinically useful outcome measures for physiotherapy airway clearance techniques: a review","volume":"11","author":"Marques","year":"2014","journal-title":"Phys Ther Rev"},{"issue":"10","key":"10.1016\/j.hrtlng.2018.09.010_bib0036","article-title":"Interventions for primary (intrinsic) tracheomalacia in children","author":"Goyal","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.hrtlng.2018.09.010_bib0037","article-title":"Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months","author":"Enriquez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.hrtlng.2018.09.010_bib0038","article-title":"Nebulised hypertonic saline solution for acute bronchiolitis in infants","author":"Zhang","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.hrtlng.2018.09.010_bib0039","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ppul.23656","article-title":"Pilot study of dornase alfa (Pulmozyme) therapy for acquired ventilator-associated infection in preterm infants","volume":"52","author":"Scala","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.hrtlng.2018.09.010_bib0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4187\/respcare.04418","article-title":"Prophylactic use of nebulized hypertonic saline in mechanically ventilated children: a randomized blinded pilot study","volume":"61","author":"Shein","year":"2016","journal-title":"Respir Care"},{"issue":"8","key":"10.1016\/j.hrtlng.2018.09.010_bib0041","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1177\/1060028014535199","article-title":"Dornase alfa for non-cystic fibrosis pediatric pulmonary atelectasis","volume":"48","author":"Thornby","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.hrtlng.2018.09.010_bib0042","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13054-016-1448-5","article-title":"Fundamentals of aerosol therapy in critical care","volume":"20","author":"Dhanani","year":"2016","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.hrtlng.2018.09.010_bib0043","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/17425247.2013.790362","article-title":"Aerosol delivery to intubated patients","volume":"10","author":"Fink","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"10.1016\/j.hrtlng.2018.09.010_bib0044","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/17476348.2017.1289843","article-title":"Inhalation therapy in patients with tracheostomy: a guide to clinicians","volume":"11","author":"Ari","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.hrtlng.2018.09.010_bib0045","doi-asserted-by":"crossref","first-page":"h4419","DOI":"10.1136\/bmj.h4419","article-title":"What is publication bias in a meta-analysis?","volume":"351","author":"Sedgwick","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.hrtlng.2018.09.010_bib0046","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1183\/09031936.00136408","article-title":"Small studies: strengths and limitations","volume":"32","author":"Hackshaw","year":"2008","journal-title":"Eur Respir J"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956318302644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956318302644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:42:15Z","timestamp":1775259735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956318302644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0147956318302644"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2018.09.010","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucoactive agents for adults with acute lung conditions: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2018.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}